References
- 1. Wang R, Wan L, Li Q, Liu X, Huang Y. Chemiluminescence of synephrine based on the cerium(IV) – rhodamine B system. Luminescence. 2007;22(2):140-6.
- 2. Watson DG, Midgley JM, Chen RN, Huang W, Bain GM, McDonald NM, et al. Analysis of biogenic amines and their metabolites in biological tissues and fluids by gas chromatography - negative ion chemical ionization mass spectrometry (GC-NICIMS). J Pharm Biomed Anal. 1990;8(8-12):899-904.
- 3. Stohs SJ. Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p-Synephrine. Phytother Res. 2017;31(10):1463-74.
- 4. Rossato LG, Costa VM, Limberger RP, Bastos Mde L, Remião F. Synephrine: from trace concentrations to massive consumption in weight-loss. Food Chem Toxicol. 2011;49(1):8-16.
- 5. Xu WW, Zheng C, Huang Y, Chen W, Yang Q, Ren J, et al. Synephrine hydrochloride suppresses esophageal cancer tumor growth and metastatic potential through inhibition of Galectin-3-AKT/ERK signaling. Agric Food Chem. 2018;66(35):9248-58.
- 6. Roh K, Kim I, Kim Y, Lee M, Lee J, Jung E, et al. Synephrine inhibits eotaxin-1 expression via the STAT6 signaling pathway. Molecules. 2014;19(8):11883-95.
- 7. Wu Q, Li R, Soromou LW, Chen N, Yuan X, Sun G, et al. p-Synephrine suppresses lipopolysaccharide-induced acute lung injury by inhibition of the NF-κB signaling pathway. Inflamm Res. 2014; 63(6):429-39.
- 8. Kim KW, Kim HD, Jung JS, Woo RS, Kim HS, Suh HW, et al. Characterization of antidepressant-like effects of p-synephrine stereoisomers. Naunyn Schmiedebergs Arch Pharmacol. 2001;364(1): 21-26.
- 9. Magos GA, Vidrio H, Reynolds WF, Enriguez RG. Pharmacology of Casimiroa edulis IV. Hypotensive effects of compounds isolated from methanolic extracts in rats and guinea pigs. J Ethnopharmacol. 1999;64(1):35-44.
- 10. Hibino T, Yuzurihara M, Kase Y, Tekeda A. Synephrine, a component of evodiae fructus, constricts isolated rat aorta via adrenergic and serotonergic receptors. J Pharmacol Sci. 2009;111(1):73-81.
- 11. Huang YT, Lin HC, Chang YY, Yang YY, Lee SD, Hong CY. Hemodynamic effects of synephrine treatment in portal hypertensive rats. Jpn J Pharmacol. 2001;85(2):183-8.
- 12. Stohs SJ, Shara M, Ray SD. p-Synephrine, ephedrine, p-octopamine and m-synephrine: Comparative mechanistic, physiological and pharmacological properties. Phytother Res. 2020;34(8):1838-46.
- 13. Hong NY, Cui ZG, Kang HK, Lee DH, Lee YK, Park DB. p-Synephrine stimulates glucose consumption via AMPK in L6 skeletal muscle cells. Biochem Biophys Res Commun. 2012;418(4):720-4.
- 14. Brown CM, McGrath JC, Midgley JM, Muir AG, O’Brien JW, Thonoor CM, et al. Activities of octopamine and synephrine stereoisomers on α-adrenoreceptors. Br J Pharmacol. 1988;93(2): 417-29.
- 15. Takagi M, Kimura K, Nakashima KI, Hirai T, Inoue M. Induction of beige adipocytes by naturally occurring β3-adrenoceptor agonist p-synephrine. Eur J Pharmacol. 2018;836:67-74.
- 16. Shara M, Stohs SJ, Smadi, MM. Safety evaluation of p-synephrine following 15 days of oral administration to healthy subjects. A clinical study. Phytother Res. 2018;32(1):125-31.
- 17. Cui Z, Lee Y, Lee Y, Park D. p-Synephrine suppresses glucose production but not lipid accumulation in H4IIE liver cells. J Med Food. 2015;18(1):76-82.
- 18. Stohs SJ, Badmaev V. A review of natural stimulant and non-stimulant thermogenic agents. Phytother Res. 2016;30(5):732-40.
- 19. Maldonado MR, Bracht L, de Sá-Nakanishi AB, Correa RCG, Comar JF, Peralta RM, et. al. Actions of p-synephrine on hepatic enzyme activities linked to carbohydrate metabolism and ATP levels in vivo and in the perfused rat liver. Cell Biochem Funct. 2018;36(1):4-12.
- 20. Taslimi P, Akıncıoglu H, Gülçin İ. Synephrine and phenylephrine act as α-Amylase, α-Glycosidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors. J Biochem Mol Toxicol. 2017;31(11).
- 21. Gutiérrez-Hellín J, Del Coso J. Effects of p-Synephrine and caffeine ingestion on substrate oxidation during exercise. Med Sci Sports Exerc. 2018;50(9):1899-906.
- 22. Guo LX, Chen G, Yin ZY, Zhang YH, Zheng XX. p-Synephrine exhibits anti-adipogenic activity by activating the Akt/GSK3β signaling pathway in 3T3-L1 adipocytes. J Food Biochem. 2019;43(11).
- 23. Haaz S, Fontaine KR, Cutter G, Limdi N, Perumean-Chaney S, Allison DB. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev. 2006;7(1):79-88.
- 24. Zheng X, Guo L, Wang D, Deng X. p-Synephrine: a novel agonist for neuromedin U2 receptor. Biol Pharm Bull. 2014;37(5):764-70.
- 25. de Oliveira AL, Comar JF, de Sá-Nakanishi AB, Peralta RM, Bracht A. The action of p-synephrine on hepatic carbohydrate metabolism and respiration occurs via both Ca2+ –mobilization and cAMP production. Mol Cell Biochem. 2014;388(1-2):135-47.
- 26. Stohs SJ, Preuss HG, Keith SC, et al. Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes. Int J Med Sci. 2011;8(4):295-301.
- 27. Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci. 2012;9(7):527-38.
- 28. Stohs SJ, Preuss HG, Shara M. The Safety of Citrus aurantium (Bitter Orange) and its Primary Protoalkaloid p-Synephrine. Phytother Res. 2011;25(10):1421-8.
- 29. Wierzejska R. Dietary supplements – panacea to contemporary health problems, or the triumph of advertisement? Med Rodz. 2017; 20(2):136-42.
- 30. Mercader J, Wanecq E, Chen J, Carpene C. Isopropylnorsynephrine is a stronger lipolytic agent in human adipocytes than synephrine and other amines present in Citrus aurantium. J Physiol Biochem. 2011;67(3):443-52.
- 31. Arbo MD, Schmitt GC, Limberger MF, Charão MF, Moro AM, Ribeiro GL, et al. Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice. Regul Toxicol Pharmacol. 2009;54(2);114-7.
- 32. Song DK, Suh HW, Jung JS, Wie MB, Son KH, Kim YH. Antidepressant-like effects of p-synephrine in mouse models of immobility tests. Neurosci Lett. 1996;214(2-3):107-10.
- 33. Deshmukh NS, Stohs SJ, Magar CC, Kadam SB. Citrus aurantium (bitter orange) extract: Safety assessment by acute and 14-day oral toxicity studies in rats and the Ames Test for mutagenicity. Regul Toxicol Pharmacol. 2017;90:318-27.